Myasthenia gravis: Myasthenia gravis (MG) is a rare, clinically heterogeneous, autoimmune disorder of the neuromuscular junction characterized by fatigable weakness of voluntary muscles.
Filter registries Inpat., Oupat., Death
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
G6_CONDEVMYA
Extra metadata
List of similar endpoints to
Congenital and developmental myasthenia
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 14 | 8 | 6 |
| Unadjusted prevalence (%) | 0.01 | 0.01 | 0.01 |
| Mean age at first event (years) | 56.51 | 47.93 | 67.95 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | - | - | - | - |
| 15 years | - | - | - | - |
| 5 years | - | - | - | - |
| 1 year | - | - | - | - |
Index endpoint: G6_CONDEVMYA – Congenital and developmental myasthenia
GWS hits:
before Congenital and developmental myasthenia
after Congenital and developmental myasthenia
Loading survival analyses plot
Loading survival analyses table